BioRestorative Therapies (BRTX) Current Leases (2020 - 2024)
Historic Current Leases for BioRestorative Therapies (BRTX) over the last 5 years, with Q3 2024 value amounting to $42414.0.
- BioRestorative Therapies' Current Leases fell 7286.55% to $42414.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $42414.0, marking a year-over-year decrease of 7286.55%. This contributed to the annual value of $162317.0 for FY2023, which is 1649.99% up from last year.
- Latest data reveals that BioRestorative Therapies reported Current Leases of $42414.0 as of Q3 2024, which was down 7286.55% from $83580.0 recorded in Q2 2024.
- BioRestorative Therapies' Current Leases' 5-year high stood at $162317.0 during Q4 2023, with a 5-year trough of $42414.0 in Q3 2024.
- In the last 5 years, BioRestorative Therapies' Current Leases had a median value of $121295.5 in 2021 and averaged $119568.3.
- Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 1819.84% in 2021, then plummeted by 7286.55% in 2024.
- Quarter analysis of 5 years shows BioRestorative Therapies' Current Leases stood at $158371.0 in 2020, then dropped by 24.83% to $119055.0 in 2021, then grew by 17.03% to $139328.0 in 2022, then increased by 16.5% to $162317.0 in 2023, then tumbled by 73.87% to $42414.0 in 2024.
- Its Current Leases stands at $42414.0 for Q3 2024, versus $83580.0 for Q2 2024 and $123536.0 for Q1 2024.